| Name | MDL 11,939,α-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol |
|---|---|
| Synonyms |
laminaritriose
Glemanserin |
| Description | Glemanserin (MDL11939) is a potent and selective antagonist for serotonin receptor 5-HT2A (Ki=2.89, 0.54 and 2.5 nM for rat 5-HT2A, rabbit 5-HT2A and human 5-HT2A, respectively)[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Glemanserin (MDL11939) suppresses Morphine-induced increase in locomotor activity, behavioral sensitization and withdrawal symptoms in male mice[1]. |
| References |
| Density | 1.084g/cm3 |
|---|---|
| Boiling Point | 434.2ºC at 760mmHg |
| Molecular Formula | C20H25NO |
| Molecular Weight | 295.41900 |
| Flash Point | 205.6ºC |
| Exact Mass | 295.19400 |
| PSA | 23.47000 |
| LogP | 3.61260 |
| Symbol |
GHS09 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H400 |
| Precautionary Statements | P273 |
| RIDADR | UN 3077 9 / PGIII |